Full Name
Email
Phone
Country
Message
Δ
Home » News & Media Coverage
PixCell Medical opens United States subsidiary bringing logistical and technical support to growing customer base, and facilitating further adoption of HemoScreen
PixCell Medical and Gamidor Diagnostics Partner to Introduce Point-of-Care Hematology Analysis in Israel
PixCell Medical Appoints Armin Schon as New Chief Commercial Officer to Foster Continued HemoScreen™ Growth
PixCell Medical Announces Acquisition by Soulbrain Holdings
PixCell Medical Partners with Axonlab to Distribute Point-of-Care Hematological Analyzer HemoScreen™ Across Europe
RURAL Cohort Study to Utilize PixCell Medical's HemoScreen™ Hematology Analyzer for Research Initiative
Aidian Appointed Sole Distributor of PixCell Medical’s Point-of-Care Hematological Analyzer HemoScreen™ in the Nordics
PixCell Medical Partners with Triolab to Distribute Hematological Analyzer HemoScreen™ in Sweden
PixCell Medical's Point-Of-Care Hematology Analyzer Can Play a Key Role in Minimizing Disease Spread
PixCell Medical Announces Regulatory Approval from Australian Therapeutic Goods Administration
PixCell Medical Bolsters its Leadership, Adding DR. David Stein as New Chairman of the Board
Partnership with Pointof Care Diagnostics, Australia
AACC's Disruptive Technology Award Competition PixCells's Hanan Ben-Asher to Present Next Generation Diagnosis and Early Detection
PixCell's Viscoelastic Focusing Technology Shifts the Paradigm in Hematology Point of Care Accessibility
Hanan Ben-Asher, COO, discusses development of a novel miniaturized portable hematology analyzer called HemoScreen™
Q&A: Study brings ‘science to the people’ to understand rural America’s health challenges
How artificial intelligence can assist primary care physicians in cancer diagnosis
PixCell's point-of-care HemoScreen outperforms laboratory CBC analysis
PixCell Medical is proud to announce that we have been named an Innovative Company in PM360’s Innovations Issue 2020!
PixCell Medical to Enhance NSW Health Pathology's Point-of-Care Testing Service
Changing Cancer Care By Bringing Diagnostics Home
POC Diagnostics and "Super Bacteria"
PixCell Plannig 2021 US Launch for HemoScreen Test, Readying Sepsis Test
Avishay Bransky, Ph.D., CEO and Co-founder of PixCell - Interview Series, by Antoine Tardif
FDA clears diagnostic device using flow and imaging cytometry
Point-of-care testing could offer a safer way to monitor cancer patients during a pandemic
The role of home-based blood diagnostics in future cancer care
Are we about to see a new dawn for point-of-care testing? , newsGP, Australia
How a Portable Israeli Blood Test Device Could Spur At-Home Chemo Treatments, NoCamels
Why Decentralized Diagnostics Are Needed for Pandemic Management, Healthcare Business Today
Bringing blood diagnostics home. Hillel's Tech Corner, The Jerusalem Post
Zealand University Hospital and PixCell Medical Cooperate to Advance Shift to Home Care to Cancer Patients, Clinical Lab Products
Happy Purim from PixCell Medical team
The HemoScreen successfully completes Clinical Evaluation with NSW Health Australia
The HemoScreen successfully completes Clinical Evaluation with the Karolinska Institute, Sweden
HemoScreen is being evaluated by Changing Cancer Care Consortium, Denmark-Germany as part of their goal to Improve, Shorten and Simplify Cancer treatment for the benefit of the patients
Pixcell Presents at the AACC Annual Meeting Anaheim,CA
The HemoScreen successfully completes Clinical Evaluation at Linköping Healthcare Center, Östergötland County, Sweden
The HemoScreen successfully complete Clinical Evaluation with Uppsala University, Uppsala County, Sweden
Pixcell's team is working hard to prevent fire and clean the Carmel forest as part of Israel National "Good Deed Day"
The HemoScreen succesfully completes Clinical Evaluation with Gimo Primary Health Center, Uppsala County, Sweden
The HemoScreen successfully completes Clinical Evaluation with Unilabs, Sweden
The HemoScreen successfully completes Clinical Evaluation with North Zealand & Rigs Hospital, Denmark
PixCell presents as the AACC 70th Annual Meeting Chicago,IL
PixCell presents at the MIXiii-BIOMED, 17th National Life Science & Technology Week
PixCell is selected as one of 10 breakthrough health techs companies emerging from Israel
The HemoScreen successfully completes Clinical Evaluation with LabCorp, US
PixCell presents at the Clinical Chemistry and Pharmacology in Uppsala Region Spring meeting
PixCell presents at the Biotech Showcase, San-Francisco, US
PixCell presents at the LINUS Days Conference, Malmo, Sweden
PixCell presents at the UK NEQAS (H) 17th Annual Meeting - Education and Innovation in Blood Sciences Birmingham, UK
PixCell presents at the International Society for Laboratory Hematology (SLH) meeting, The Hague, The Netherlands
HemoScreen has won 1st place (gold) in the Testing and Diagnostic Products category, and best in show overall in the MDDI Medical Design Excellence Awards.
PixCell Medical is the winner of the 2021 MedTech Visionaries Awards' best medtech visionary in the field of medical devices for real-time blood testing
The HemoScreen has won the Juniper Research Digital Health Innovation 2021 Award for Best Digital Diagnostic and Best Health Monitoring Device
The HemoScreen technology has been selected as Finalist for the AACC Disruptive Technology Award at the AACC Annual Meeting 2019, Anehaim, CA.
HemoScreen Recieves FDA 510(k) Clearance making it the first Cartridge Base True Point of Care Hematology Analyzer that brings critical tests to the doctor's office
PixCell's HemoScreen has been selected for display at the Israel Innovation Expo first cohort at the Peres Center for Innovation and Peace
PixCell Medical wins the MIXii-BIOMED 2018 International Life Science Conference
PixCell had been awarded $3M by the European Innovation Commission to expedite the HemoScreen commercialization and disrupt the POC Hematology diagnostics market
The HemoScreen receives CE mark for use in the European Union
Dev by RNCode | Design by Adi
